Merger

Recorded: 2003-02-26 Received: 2003-03-03 Pages: 10

Assignor

ANDRX PHARMACEUTICALS, INC.

Executed: 2002-12-18

Assignee

ANDRX PHARMACEUTICALS, LLC

4955 ORANGE DRIVE, DAVIE, FL, 33314, UNITED STATES

Covered Properties (12)

Stable Pharmaceutical Compositions Without a Stabilizer

Application: 10/301,474 →

Antihistamine and Decongestant System

Application: 10/291,103 →

Omeprazole Formulation

Application: 10/279,622 →

Once a Day Antihistamine and Decongestant Formulation

Application: 10/244,452 →

Rapidly disintegrating antihistamine formulation

Application: 10/183,771 →

Controlled release oral dosage form

Application: 10/183,776 →

Controlled Release Oral Dosage Form of Beta-Adrenergic Blocking Agents

Application: 10/109,408 →

Controlled release oral dosage form

Application: 10/071,257 →

Controlled Release Oral Tablet Having a Unitary Core

Application: 10/016,556 →

Omeprazole Formulation

Application: 09/763,831 →

Divalproex Sodium Tablets

Application: 09/785,069 →

Controlled Release Oral Dosage Form

Application: 09/905,712 →